Cullinan Therapeutics Cash Flow Statement 2019-2024 | CGEM

Fifteen years of historical annual cash flow statements for Cullinan Therapeutics (CGEM).

Annual Data | Millions of US $ except per share data

Metric Name
Net Income/Loss
Total Depreciation And Amortization - Cash Flow
Other Non-Cash Items
Total Non-Cash Items
Change In Accounts Receivable
Change In Inventories
Change In Accounts Payable
Change In Assets/Liabilities
Total Change In Assets/Liabilities
Cash Flow From Operating Activities
Net Change In Property, Plant, And Equipment
Net Change In Intangible Assets
Net Acquisitions/Divestitures
Net Change In Short-term Investments
Net Change In Long-Term Investments
Net Change In Investments - Total
Investing Activities - Other
Cash Flow From Investing Activities
Net Long-Term Debt
Net Current Debt
Debt Issuance/Retirement Net - Total
Net Common Equity Issued/Repurchased
Net Total Equity Issued/Repurchased
Total Common And Preferred Stock Dividends Paid
Financial Activities - Other
Cash Flow From Financial Activities
Net Cash Flow
Stock-Based Compensation
Common Stock Dividends Paid
20232022202120202019
$-155.10$109$-67.49$-59.46$-21.65
$0.31$0.09$0.05$0.06$0.07
$20.86$-247.13$27.54$22.77$0.55
$21.17$-247.04$27.59$22.84$0.62
$0$0$0$0$0
$0$0$0$0$0
$-0.17$-0.51$-4.84$5.58$0.64
$-5.94$-1.13$-3.27$-0.48$-1.06
$-0.34$11.18$-3.54$6.85$0.14
$-134.28$-126.66$-43.43$-29.77$-20.90
$-0.21$-1.04$0$-0.01$-0.02
$0$0$0$0$0
$0$275$0$1.45$0
$0$0$0$0$0
$36.01$-24.98$-333.78$-6.86$-35.38
$36.01$-24.98$-333.78$-6.86$-35.38
$0$0$0$0$0
$35.81$249$-333.78$-5.42$-35.40
$0$0$0$0$0
$1.83$0.18$0$0$0
$1.83$0.18$0$0$0
$38.93$6.02$271$146$0
$38.93$6.02$271$146$84.25
$0$0$0$0$0
$0$-32.13$-1.77$-5.37$1.47
$40.75$-25.93$269$140$85.72
$-57.72$96.38$-108.42$105$29.42
$30.44$27.96$24.38$14.91$0.02
$0$0$0$0$0